Breaking News Instant updates and real-time market news.

TECH

Bio-Techne

$203.89

-0.4 (-0.20%)

07:50
10/02/18
10/02
07:50
10/02/18
07:50

Bio-Techne price target raised to $230 from $210 at Argus

Argus analyst David Toung raised his price target on Bio-Techne to $230 and kept his Buy rating, saying the company appears to be on track for ongoing "solid" revenue growth thanks to the domestic and international demand for its products. The analyst is also positive on Bio-Techne's continued expansion through acquisitions such as its recent purchase of Quad Technologies, producing advanced reagents for clinical and research use, and Exosome Diagnostics, marketing a noninvasive liquid biopsy diagnostic test for prostate cancer. Tough further cites the company's internal development, including its "recent initiative to advance cell and gene therapy research and ex vivo cell processing".

  • 06

    Nov

TECH Bio-Techne
$203.89

-0.4 (-0.20%)

06/27/18
06/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Molina Healthcare (MOH) downgraded to Neutral from Overweight at JPMorgan with analyst Gary Taylor saying he sees a high probability that Molina will retain its $2.2B 2020 Texas Medicaid contracts, but he does not like the downside risk heading into that Q3 re-procurement announcement. 2. Bio-Techne (TECH) downgraded to Hold from Buy at Deutsche Bank with analyst Dan Leonard stating that he increasingly questions the durability of its organic sales growth. 3. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying he sees limited upside to valuation at current levels following the recent upward inflection in the share price. 4. NuVasive (NUVA) downgraded to Underperform from Neutral at BofA/Merrill with analyst Bob Hopkins stating that he is skeptical NuVasive can consistently drive high single digit revenue growth due to robotics momentum in the marketplace and lack of a differentiated product. 5. Wesco (WCC) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying its recent inability to translate increasing sales to incremental margin is reflective of the more competitive electrical distribution market it serves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/18
LEER
08/08/18
NO CHANGE
Target $190
LEER
Outperform
Bio-Techne price target raised to $190 from $160 at Leerink
Leerink analyst Puneet Souda raised his price target for Bio-Techne to $190 from $160 following a "strong" quarter. The analyst reiterates an Outperform rating on the shares as he believes its consumables-heavy portfolio remains differentiated, contributing to above-industry growth and margins in his Life Science Tools coverage universe.
08/08/18
BARD
08/08/18
NO CHANGE
Target $191
BARD
Outperform
Bio-Techne price target raised to $191 from $162 at Baird
Baird analyst Catherine Ramsey Schulte raised her price target on Bio-Techne to $191 from $162 following Q4 results. The analyst said the end market commentary remained positive and guidance was solid. She continues to have a positive outlook on the company's core business and believes its recent acquisitions could drive upside over time. Schulte reiterated her Outperform rating on Bio-Techne shares.
08/08/18
CHLM
08/08/18
NO CHANGE
Target $215
CHLM
Buy
Bio-Techne price target raised to $215 from $160 at Craig-Hallum
Craig-Hallum analyst Matt Hewitt raised his price target for Bio-Techne to $215 from $160, while reiterating a Buy rating on the shares. The analyst notes that the company added two avenues for growth via the recent acquisitions of Exosome Diagnostics and Quad Technologies. With these companies added to the fold, Bio-Techne suddenly becomes well positioned around oncology with solutions that address research, diagnostics, and therapy needs as the company migrates closer to the patient, he contends.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
01/16/19
01/16
11:17
01/16/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
01/16/19
01/16
11:16
01/16/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CF

CF Industries

$42.03

-1.26 (-2.91%)

11:15
01/16/19
01/16
11:15
01/16/19
11:15
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

11:15
01/16/19
01/16
11:15
01/16/19
11:15
General news
U.S. VIX equity volatility rose 1.8% to probe 19.0 »

U.S. VIX equity…

SIG

Signet Jewelers

$33.76

-0.05 (-0.15%)

11:14
01/16/19
01/16
11:14
01/16/19
11:14
Hot Stocks
Signet Jewelers says to pay total of $11M to CFPB, NYS in investigations »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$98.39

-2.03 (-2.02%)

11:13
01/16/19
01/16
11:13
01/16/19
11:13
Rumors
Rumor moving shares of Twilio »

Rumor: Twilio moves off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 12

    Feb

11:10
01/16/19
01/16
11:10
01/16/19
11:10
General news
Treasury Action: curve steepening has been the general trend this year »

Treasury Action: curve…

SQ

Square

$66.03

0.13 (0.20%)

, FISV

Fiserv

$70.17

-4.84 (-6.45%)

11:09
01/16/19
01/16
11:09
01/16/19
11:09
Recommendations
Square, Fiserv, First Data analyst commentary  »

Fiserv deal for First…

SQ

Square

$66.03

0.13 (0.20%)

FISV

Fiserv

$70.17

-4.84 (-6.45%)

FDC

First Data

$20.72

3.17 (18.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

11:05
01/16/19
01/16
11:05
01/16/19
11:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

YELP

Yelp

$35.64

0.67 (1.92%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Breaking Hot Stocks news story on Yelp »

Yelp says to review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.65

0.68 (1.94%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Breaking Hot Stocks news story on Yelp »

Yelp says 'willing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.65

0.68 (1.94%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Yelp says 'open to hearing ideas and investor input, including from SQN' »

Yelp issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$43.85

-3.41 (-7.22%)

11:02
01/16/19
01/16
11:02
01/16/19
11:02
Downgrade
Nordstrom rating change  »

Nordstrom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KEYS

Keysight Technologies

$68.05

-0.47 (-0.69%)

11:01
01/16/19
01/16
11:01
01/16/19
11:01
Hot Stocks
Keysight Technologies, others sign agreement with UNISOC »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$4.24

0.08 (1.92%)

11:00
01/16/19
01/16
11:00
01/16/19
11:00
Options
Call buyer in BioDelivery Sciences International as the rally continues »

Call buyer in BioDelivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
01/16/19
01/16
11:00
01/16/19
11:00
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

JPM

JPMorgan

$102.15

0.45 (0.44%)

10:55
01/16/19
01/16
10:55
01/16/19
10:55
Conference/Events
Economic Club of New York to hold a luncheon meeting »

JPMorgan Chairman &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 26

    Feb

APA

Apache

$31.93

0.17 (0.54%)

10:50
01/16/19
01/16
10:50
01/16/19
10:50
Options
Aggressive option play opened in Apache as shares extend gains »

Aggressive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

EA

Electronic Arts

$86.34

-3.14 (-3.51%)

, ATVI

Activision Blizzard

$45.89

-0.92 (-1.97%)

10:48
01/16/19
01/16
10:48
01/16/19
10:48
Recommendations
Electronic Arts, Activision Blizzard analyst commentary  »

Stephens a buyer of…

EA

Electronic Arts

$86.34

-3.14 (-3.51%)

ATVI

Activision Blizzard

$45.89

-0.92 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 12

    Feb

  • 25

    Feb

UAL

United Continental

$86.50

5.27 (6.49%)

10:48
01/16/19
01/16
10:48
01/16/19
10:48
Hot Stocks
United Continental 'paying close attention to government shutdown' »

CEO Oscar Munoz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 04

    Mar

DB

Deutsche Bank

$9.01

0.39 (4.52%)

10:42
01/16/19
01/16
10:42
01/16/19
10:42
Periodicals
Deutsche Bank regulators said to favor European merger, Bloomberg says »

The ECB is said to favor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,088.98

12.07 (1.12%)

, GOOGL

Alphabet Class A

$1,098.50

12.14 (1.12%)

10:42
01/16/19
01/16
10:42
01/16/19
10:42
Hot Stocks
Google's YouTube banning 'dangerous challenges and pranks' »

In an update to their…

GOOG

Alphabet

$1,088.98

12.07 (1.12%)

GOOGL

Alphabet Class A

$1,098.50

12.14 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

SM

SM Energy

$20.07

0.24 (1.21%)

10:40
01/16/19
01/16
10:40
01/16/19
10:40
Options
Bullish option flow in SM Energy after analyst action »

Bullish option flow in SM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$17.22

-1.1 (-6.00%)

10:35
01/16/19
01/16
10:35
01/16/19
10:35
Recommendations
Adient analyst commentary  »

Adient shares to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 07

    Feb

10:35
01/16/19
01/16
10:35
01/16/19
10:35
General news
Today's U.S. NAHB Bounce to 58 »

Today's U.S. NAHB…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.